Skip to main content
. 2023 Jun 2;14:1141059. doi: 10.3389/fneur.2023.1141059

Table 1.

Demographics and clinical characteristics categorized according to the final diagnosis.

Variable Stroke N = 581 Mimic N = 240 Uncertain N = 53 value of p
Age, mean years (SD) 66.6 (14.3) 58.8 (16.5) 58.2 (17.2) <0.0001
Female, n (%) 287 (49.4) 150 (62.5) 36 (67.9) 0.0003
NIHSS >10, n (%) 406 (72.1) 191 (84.5) 49 (94.2) <0.0001
Comorbidities, n (%)
Smoking 229 (39.5) 89 (37.4) 23 (44.2) 0.6403
Hypertension 488 (84.0) 170 (70.8) 39 (73.6) <0.0001
Diabetes mellitus 253 (43.6) 80 (33.3) 20 (37.7) 0.0222
Hyperlipidemia 295 (50.8) 103 (42.9) 20 (37.7) 0.038
Coronary artery disease 160 (27.5) 46 (19.2) 6 (11.3) 0.0019
Cerebrovascular disease 165 (28.4) 77 (32.1) 23 (43.3) 0.0672
tPA administered, n (%) 190 (32.7) 13 (5.4) 1 (1.9) <0.0001
Bleeding post tPA 23 (12.1) 0 (0.0) 0 (0.0) 0.1757*
LKN time, no. (%)
12:01 AM – 6:00 AM 42 (8.3) 10 (5.5) 1 (2.3) 0.5548*
6:01 AM – 12:00 PM 165 (32.7) 10 (33.9) 17 (39.5)
12:01 PM – 6:00 PM H 168 (33.3) 10 (33.9) 12 (27.9)
6:01 PM – 12:00 AM 129 (25.6) 49 (26.8) 13 (30.2)

Demographics and clinical characteristics categorized according to the final diagnosis. NIHSS, National Institutes of Health Stroke Scale; tPA, tissue plasminogen activator; LKN, last known normal. Bold indicates a significant p value. *Fisher’s exact value could not be calculated, therefore Chi-square values were reported.